We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
10 Year Est. Return
AUM
$2.5B
AUM Growth
+$282M
Cap. Flow
+$50.2M
Cap. Flow %
2.01%
Top 10 Hldgs %
47.96%
Holding
42
New
2
Increased
13
Reduced
24
Closed
1

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$54.3M
2
PGEN icon
Precigen
PGEN
+$28.8M
3
ET icon
Energy Transfer Partners
ET
+$14.2M
4
PPLI
People Inc
PPLI
+$13.8M
5
MAT icon
Mattel
MAT
+$11.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.94%
2 Healthcare 22.45%
3 Communication Services 15.15%
4 Financials 14.98%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.36T
$149M 5.97%
613,333
+280
+0% +$58.6K
C icon
2
Citigroup
C
$226B
$133M 5.32%
1,310,407
-35,310
-3% -$3.35M
UNH icon
3
UnitedHealth
UNH
$372B
$128M 5.13%
371,363
+179,431
+93% +$54.3M
QXO
4
QXO Inc
QXO
$17.1B
$125M 4.99%
6,537,027
-5,175
-0.1% -$107K
AMZN icon
5
Amazon
AMZN
$3T
$123M 4.94%
561,976
-1,506
-0.3% -$341K
NVDA icon
6
NVIDIA
NVDA
$5.43T
$118M 4.73%
632,684
-1,489
-0.2% -$260K
NCLH icon
7
Norwegian Cruise Line
NCLH
$8.83B
$112M 4.5%
4,564,871
-143,708
-3% -$3.49M
RPRX icon
8
Royalty Pharma
RPRX
$25.3B
$110M 4.4%
3,117,850
+129,862
+4% +$4.7M
META icon
9
Meta Platforms (Facebook)
META
$1.52T
$106M 4.23%
144,000
-295
-0.2% -$220K
CVS icon
10
CVS Health
CVS
$122B
$93.5M 3.74%
1,239,894
-2,030
-0.2% -$139K
BABA icon
11
Alibaba
BABA
$307B
$87.5M 3.5%
489,677
-9,433
-2% -$1.24M
PGEN icon
12
Precigen
PGEN
$2.53B
$87.1M 3.48%
26,460,848
+10,192,107
+63% +$28.8M
ET icon
13
Energy Transfer Partners
ET
$70B
$83.9M 3.36%
4,888,138
+811,782
+20% +$14.2M
PPLI
14
People Inc
PPLI
$3.2B
$71.8M 2.88%
2,108,245
+369,239
+21% +$13.8M
SDRL icon
15
Seadrill
SDRL
$2.73B
$67.4M 2.7%
2,229,936
+387
+0% +$11.8K
UAL icon
16
United Airlines
UAL
$41.7B
$64.3M 2.57%
666,515
-2,136
-0.3% -$205K
FBTC icon
17
Fidelity Wise Origin Bitcoin Fund
FBTC
$12.1B
$61.9M 2.48%
619,752
-474
-0.1% -$47.4K
UBS icon
18
UBS Group
UBS
$176B
$61.5M 2.46%
1,500,849
-436,790
-23% -$17M
SOFI icon
19
SoFi Technologies
SOFI
$23.5B
$59.6M 2.38%
2,254,066
-903,365
-29% -$21.4M
COIN icon
20
Coinbase
COIN
$40.3B
$58M 2.32%
171,736
-31,764
-16% -$10.8M
GM icon
21
General Motors
GM
$76.8B
$57.3M 2.3%
940,597
-4,156
-0.4% -$232K
BIIB icon
22
Biogen
BIIB
$30.2B
$55.6M 2.22%
396,649
+76,183
+24% +$10.3M
ILMN icon
23
Illumina
ILMN
$29B
$55.2M 2.21%
581,359
-831
-0.1% -$82.4K
EXPE icon
24
Expedia Group
EXPE
$37.3B
$54.2M 2.17%
253,477
-8,378
-3% -$1.68M
OMF icon
25
OneMain Financial
OMF
$7.43B
$52.9M 2.12%
936,913
-95,588
-9% -$5.64M

Similar funds

Patient Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Patient Capital Management held 42 positions worth $2.5B, up 13% from $2.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Patient Capital Management's Q3 2025 filing shows 2 new, 13 increased, 24 reduced and 1 closed positions. Its largest new stake was Strategy Inc: 2,092 shares worth $674K. The largest sale was Kosmos Energy, an estimated $30M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.

  • Patient Capital Management's largest Q3 2025 buy was Strategy Inc: 2,092 shares worth $674K.
  • Patient Capital Management added most to UnitedHealth in Q3 2025, an estimated $54.3M increase.
  • Patient Capital Management's biggest Q3 2025 reduction was Kosmos Energy, cutting an estimated $30M.
  • Patient Capital Management fully exited Canada Goose Holdings in Q3 2025, selling an estimated $8.23M.
  • Patient Capital Management's ten largest holdings make up 48% of its $2.5B portfolio in Q3 2025.
  • Patient Capital Management opened 2 new positions and closed 1 in Q3 2025.
  • Patient Capital Management's portfolio value rose 13% quarter-over-quarter to $2.5B.

Based on Patient Capital Management's 13F filing for Q3 2025, filed 30 Oct 2025.